A new trading day began on Tuesday, with Kezar Life Sciences Inc (NASDAQ: KZR) stock price up 2.68% from the previous day of trading ,before settling in for the closing price of $0.81. KZR’s price has ranged from $0.67 to $3.13 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 3.45%. With a float of $60.30 million, this company’s outstanding shares have now reached $72.78 million.
The firm has a total of 58 workers. Let’s measure their productivity.
Kezar Life Sciences Inc (KZR) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Kezar Life Sciences Inc is 15.01%, while institutional ownership is 66.78%.
Kezar Life Sciences Inc (KZR) Earnings and Forecasts
In its latest quarterly report, released on 12/30/2023, the company reported earnings of -$0.44 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 3.45% per share during the next fiscal year.
Kezar Life Sciences Inc (NASDAQ: KZR) Trading Performance Indicators
Here are Kezar Life Sciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 11.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.40, a number that is poised to hit -0.33 in the next quarter and is forecasted to reach -1.25 in one year’s time.
Technical Analysis of Kezar Life Sciences Inc (KZR)
Analysing the last 5-days average volume posted by the [Kezar Life Sciences Inc, KZR], we can find that recorded value of 0.81 million was better than the volume posted last year of 0.71 million. As of the previous 9 days, the stock’s Stochastic %D was 29.32%. Additionally, its Average True Range was 0.07.
During the past 100 days, Kezar Life Sciences Inc’s (KZR) raw stochastic average was set at 29.56%, which indicates a significant increase from 27.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.96% in the past 14 days, which was higher than the 55.35% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9142, while its 200-day Moving Average is $1.2141. Now, the first resistance to watch is $0.8405. This is followed by the second major resistance level at $0.8523. The third major resistance level sits at $0.8726. If the price goes on to break the first support level at $0.8084, it is likely to go to the next support level at $0.7881. Should the price break the second support level, the third support level stands at $0.7763.
Kezar Life Sciences Inc (NASDAQ: KZR) Key Stats
With a market capitalization of 58.79 million, the company has a total of 72,801K Shares Outstanding. Currently, annual sales are 7,000 K while annual income is -101,870 K. The company’s previous quarter sales were 7,000 K while its latest quarter income was -23,100 K.
